BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2026.
World J Gastroenterol. Jan 14, 2026; 32(2): 113810
Published online Jan 14, 2026. doi: 10.3748/wjg.v32.i2.113810
Table 2 Residual tumor and local recurrence rates as a function of lesion size and treatment group, n (%)

Residual tumor (n = 491 nodules)
Local tumor progression (n = 436 nodules)
TotalMWA (n = 168)21 (12.5)MWA (n = 147)37 (25.2)
Mbp-RFA (n = 323)19 (5.9)Mbp-RFA (n = 289)33 (11.4)
P value0.01P value0.002
< 30 mmMWA (n = 141)17 (12.1)MWA (n = 124)23 (18.5)
Mbp-RFA (n = 227)15 (6.6)Mbp-RFA (n = 201)17 (7)
P value0.071P value< 0.002
≥ 30 mmMWA (n = 27)4 (14.8)MWA (n = 23)14 (60.9)
Mbp-RFA (n = 96)4 (4.2)Mbp-RFA (n = 88)19 (21.6)
P value0.069P value0.04


Write to the Help Desk